Your browser doesn't support javascript.
loading
Modified-release hydrocortisone is associated with lower plasma renin activity in patients with salt-wasting congenital adrenal hyperplasia.
Tschaidse, Lea; Reisch, Nicole; Arlt, Wiebke; Brac de la Perriere, Aude; Linden Hirschberg, Angelica; Juul, Anders; Mallappa, Ashwini; Merke, Deborah P; Newell-Price, John D C; Perry, Colin G; Prete, Alessandro; Rees, D Aled; Stikkelbroeck, Nike M M L; Touraine, Philippe A; Coope, Helen; Porter, John; Ross, Richard John M; Quinkler, Marcus.
Afiliação
  • Tschaidse L; Medizinische Klinik und Poliklinik IV, Klinikum der Universität München, Munich, Germany.
  • Reisch N; Medizinische Klinik und Poliklinik IV, Klinikum der Universität München, Munich, Germany.
  • Arlt W; Institute of Metabolism and Systems Research (IMSR), University of Birmingham, Birmingham, United Kingdom.
  • Brac de la Perriere A; Hospices Civils de Lyon, Fédération d'Endocrinologie, Groupement hospitalier Est, Bron Cedex, France.
  • Linden Hirschberg A; Department of Women's and Children's Health, Karolinska Institutet and Department of Gynecology and Reproductive Medicine, Karolinska University Hospital, Stockholm, Sweden.
  • Juul A; Department of Growth and Reproduction, Copenhagen University Hospital - Rigshospitalet, Copenhagen, Denmark.
  • Mallappa A; Department of Clinical Medicine, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark.
  • Merke DP; AstraZeneca, Gaithersburg, Maryland, United States.
  • Newell-Price JDC; National Institutes of Health Clinical Center, Bethesda, Maryland, United States.
  • Perry CG; National Institutes of Health Clinical Center, Bethesda, Maryland, United States.
  • Prete A; Eunice Kennedy Shriver National Institute of Child Health and Human Development, Bethesda, Maryland, United States.
  • Rees DA; University of Sheffield, Sheffield, United Kingdom.
  • Stikkelbroeck NMML; Queen Elizabeth University Hospital, Glasgow, United Kingdom.
  • Touraine PA; Institute of Metabolism and Systems Research (IMSR), University of Birmingham, Birmingham, United Kingdom.
  • Coope H; Neuroscience and Mental Health Research Institute, School of Medicine, Cardiff University, Cardiff, United Kingdom.
  • Porter J; Radboud University Medical Center, Nijmegen, Netherlands.
  • Ross RJM; University Hospitals Pitié Salpêtrière - Charles Foix, Center for Rare Endocrine and Gynecological Disorders, Paris, France.
  • Quinkler M; Diurnal Ltd, Cardiff, United Kingdom.
Eur J Endocrinol ; 188(1)2023 Jan 10.
Article em En | MEDLINE | ID: mdl-36654495
Assuntos
Palavras-chave
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Hidrocortisona / Hiperplasia Suprarrenal Congênita Tipo de estudo: Risk_factors_studies Limite: Humans Idioma: En Revista: Eur J Endocrinol Assunto da revista: ENDOCRINOLOGIA Ano de publicação: 2023 Tipo de documento: Article País de afiliação: Alemanha País de publicação: Reino Unido
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Hidrocortisona / Hiperplasia Suprarrenal Congênita Tipo de estudo: Risk_factors_studies Limite: Humans Idioma: En Revista: Eur J Endocrinol Assunto da revista: ENDOCRINOLOGIA Ano de publicação: 2023 Tipo de documento: Article País de afiliação: Alemanha País de publicação: Reino Unido